Aeva

Management has prioritized R&D and manufacturing partnerships to scale chip‑level FMCW, which is consistent with the strategic need to win design‑ins.

However, dilution has been meaningful: a 1‑for‑5 reverse split in 2024, 100 million dollars convertible notes in 2025, and a 115 million dollars equity raise in June 2026. Stock‑based compensation is sizable relative to revenue, and the company relies on a standby preferred facility for optional liquidity.

There is no record of value‑accretive buybacks or dividends, which is sensible at this stage but underscores dependence on external capital while free cash flow is negative. Capital intensity is acceptable if it yields a durable moat, yet proof via gross margin and cash conversion is still pending.